Atherosclerosis as a potential pitfall in the diagnosis of giant cell arteritis

Eugenio De Miguel1, Luis M Beltran2, Irene Monjo1

  • 1Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain.

Insights

Arteriosclerotic disease increases intima-media thickness (IMT) in temporal arteries, potentially mimicking the ultrasound halo sign in Giant Cell Arteritis (GCA). A threshold of TA IMT >0.34 mm in two branches helps reduce false positives for GCA.

Area of Science:

  • Vascular Ultrasound
  • Arterial Imaging
  • Rheumatology

Background:

  • Giant Cell Arteritis (GCA) diagnosis relies on clinical signs and imaging.
  • The ultrasound halo sign in temporal arteries (TAs) is a key indicator for GCA.
  • Atherosclerosis can affect IMT and potentially mimic GCA signs.

Purpose of the Study:

  • To investigate the correlation between intima-media thickness (IMT) in arteriosclerotic disease and TA IMT.
  • To determine if increased IMT in arteriosclerosis can mimic the ultrasound GCA halo sign.

Main Methods:

  • Carotid and TA IMT measurements using standardized ultrasound software and a 22 MHz probe.
  • Inclusion of consecutive patients aged 50+ with high vascular risk, excluding GCA symptoms.
  • Correlation analysis between carotid IMT and TA IMT.

Main Results:

  • Significant correlation found between carotid IMT and TA IMT.
  • Carotid IMT >0.9 mm was associated with TA IMT >0.3 mm.
  • Only one patient exceeded the proposed TA IMT threshold.

Conclusions:

  • Arteriosclerotic disease, particularly with carotid IMT >0.9 mm, elevates TA IMT.
  • Elevated TA IMT may mimic the halo sign, leading to potential misdiagnosis of GCA.
  • A TA IMT cut-off of >0.34 mm in at least two branches is proposed to minimize false positives in GCA diagnosis.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
587
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.4K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
391
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
420
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
581